Back
Mirum Pharmaceuticals Vs. Summit Therapeutics Industry Stock Comparison
Buy
54
MIRM
Mirum Pharmaceuticals
Last Price:
$43.36
Seasonality Move:
10.4%
Sell
46
SMMT
Summit Therapeutics
Last Price:
$16.66
Seasonality Move:
7.78%
Buy
54
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
-
The current Mirum Pharmaceuticals [MIRM] share price is $43.32. The Score for MIRM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
MIRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $16.65. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $43.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing selling pressure, which indicates risk of future bearish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $16.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 54.28 | Buy |
Chaikin Money Flow: | -781328 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.36 - 43.38) | Buy |
Bollinger Bands (100): | (39.42 - 43.62) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 40.61 | Sell |
Chaikin Money Flow: | -2642249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.6 - 18.78) | Sell |
Bollinger Bands (100): | (15.7 - 22.62) | Sell |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.58 | Buy |
20-day SMA: | 42.07 | Buy |
50-day SMA: | 42.83 | Buy |
200-day SMA: | 36.12 | Buy |
8-day EMA: | 42.62 | Buy |
20-day EMA: | 42.49 | Buy |
50-day EMA: | 42.26 | Buy |
200-day EMA: | 37.73 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.96 | Sell |
20-day SMA: | 18.15 | Sell |
50-day SMA: | 18.76 | Sell |
200-day SMA: | 13.03 | Buy |
8-day EMA: | 17.83 | Sell |
20-day EMA: | 18.12 | Sell |
50-day EMA: | 18.46 | Sell |
200-day EMA: | 14.25 | Buy |
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $2.04 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.
Mirum Pharmaceuticals Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |